[PHARMA] YoY Cumulative Quarter Result on 30-Jun-2015 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
17-Aug-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
30-Jun-2015 [#2]
Profit Trend
QoQ- 51.01%
YoY- 13.79%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Revenue 1,200,652 1,136,261 1,090,991 984,749 993,744 937,972 903,482 4.85%
PBT 40,677 37,927 48,025 63,668 62,781 46,529 70,573 -8.77%
Tax -17,322 -8,918 -13,914 -15,100 -20,178 -15,205 -25,435 -6.19%
NP 23,355 29,009 34,111 48,568 42,603 31,324 45,138 -10.39%
-
NP to SH 22,980 28,443 33,374 48,011 42,192 30,636 44,398 -10.39%
-
Tax Rate 42.58% 23.51% 28.97% 23.72% 32.14% 32.68% 36.04% -
Total Cost 1,177,297 1,107,252 1,056,880 936,181 951,141 906,648 858,344 5.40%
-
Net Worth 519,642 541,894 524,041 527,991 502,162 481,681 481,282 1.28%
Dividend
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Div 23,383 20,742 23,302 36,234 20,707 17,661 17,650 4.79%
Div Payout % 101.76% 72.93% 69.82% 75.47% 49.08% 57.65% 39.76% -
Equity
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Net Worth 519,642 541,894 524,041 527,991 502,162 481,681 481,282 1.28%
NOSH 259,821 259,279 258,913 258,819 258,846 258,968 117,672 14.10%
Ratio Analysis
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
NP Margin 1.95% 2.55% 3.13% 4.93% 4.29% 3.34% 5.00% -
ROE 4.42% 5.25% 6.37% 9.09% 8.40% 6.36% 9.22% -
Per Share
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
RPS 462.11 438.24 421.37 380.48 383.91 362.20 767.79 -8.11%
EPS 8.84 10.97 12.89 18.55 16.30 11.83 37.73 -21.47%
DPS 9.00 8.00 9.00 14.00 8.00 6.82 15.00 -8.15%
NAPS 2.00 2.09 2.024 2.04 1.94 1.86 4.09 -11.23%
Adjusted Per Share Value based on latest NOSH - 259,057
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
RPS 83.31 78.84 75.70 68.33 68.95 65.08 62.69 4.85%
EPS 1.59 1.97 2.32 3.33 2.93 2.13 3.08 -10.42%
DPS 1.62 1.44 1.62 2.51 1.44 1.23 1.22 4.83%
NAPS 0.3605 0.376 0.3636 0.3663 0.3484 0.3342 0.3339 1.28%
Price Multiplier on Financial Quarter End Date
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Date 29/06/18 30/06/17 30/06/16 30/06/15 30/06/14 28/06/13 29/06/12 -
Price 2.88 4.58 5.50 7.13 4.61 4.49 10.18 -
P/RPS 0.62 1.05 1.31 1.87 1.20 1.24 1.33 -11.93%
P/EPS 32.56 41.75 42.67 38.44 28.28 37.95 26.98 3.18%
EY 3.07 2.40 2.34 2.60 3.54 2.63 3.71 -3.10%
DY 3.13 1.75 1.64 1.96 1.74 1.52 1.47 13.41%
P/NAPS 1.44 2.19 2.72 3.50 2.38 2.41 2.49 -8.71%
Price Multiplier on Announcement Date
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Date 17/08/18 16/08/17 19/08/16 17/08/15 21/08/14 16/08/13 08/08/12 -
Price 3.11 4.19 5.62 5.65 4.62 4.66 8.83 -
P/RPS 0.67 0.96 1.33 1.48 1.20 1.29 1.15 -8.60%
P/EPS 35.16 38.20 43.60 30.46 28.34 39.39 23.40 7.01%
EY 2.84 2.62 2.29 3.28 3.53 2.54 4.27 -6.56%
DY 2.89 1.91 1.60 2.48 1.73 1.46 1.70 9.24%
P/NAPS 1.56 2.00 2.78 2.77 2.38 2.51 2.16 -5.27%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment